In addition, multi-combination immunotherapy, i.e., nanoscale reduced graphene oxide-mediated photothermal therapy synergized with IDO inhibition and PD-L1 blockade, designed by Yan et al. was shown to directly kill tumor cells and induce synergistic anti-tumor immunity. The gene discussed is IDO1; the disease is neoplasm.